A recent review summarizes what is known about these conditions and suggests future research directions and opportunities.
Obesity and type 2 diabetes (T2D) drugs have provided significant increases in revenue growth. Credit: encierro via Shutterstock. Novo Nordisk and Eli Lilly have posted
The Food and Drug Administration recently approved Opill, the first over-the-counter access birth control pill, in a monumental and long overdue win for reproductive and
To most people on the planet, the Covid-19 pandemic is over. But for many scientists who have been tracking the largest global infectious disease event
Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech
Treatment of obesity has never been more prominent, with the advent of medications like Ozempic and Mounjaro generating both excitement and concern. Overlooked, however, is
In recent weeks, you may have seen alarming headlines about how leprosy might become “endemic” in Florida. As a physician in Florida who specializes in
The pharmaceutical market in China has been hit by the general downturn. Credit: Alex Verrone/Shutterstock. China has been an increasingly appealing market for Western pharmaceutical
Regeneron will receive $326m to develop a new monoclonal antibody to prevent Covid-19 infection. Credit: Viacheslav Lopatin / Shutterstock.com. The US Department of Health and
Andy Coville, CEO, Brodeur Partners Alice Holland, Ph.D., NP-C, CSE Nurses have the highest level of public trust across medical professions, yet there’s a huge